Lung Adenocarcinoma Patient Harboring EGFR-KDD Achieve Durable Response to Afatinib: A Case Report and Literature Review.
Front Oncol. 2021 Apr 7;11:605853. doi: 10.3389/fonc.2021.605853. eCollection 2021.
Front Oncol. 2021.
PMID: 33898306
Free PMC article.